blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1539795

EP1539795 - CRYSTALLINE 17BETA-HYDROXY-7ALPHA-(5'-METHYL-2'-FURYL)-PREGNA-4,9(11)-DIEN-3-ONE-21-CARBOXYLIC ACID, GAMMA-LACTONE [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  05.09.2008
Database last updated on 14.09.2024
Most recent event   Tooltip13.08.2010Lapse of the patent in a contracting state
New state(s): TR
published on 15.09.2010  [2010/37]
Applicant(s)For all designated states
Pharmacia & Upjohn Company LLC
7000 Portage Road
Kalamazoo, MI 49001 / US
[2007/04]
Former [2005/24]For all designated states
Pharmacia & Upjohn Company LLC
301 Henrietta Street
Kalamazoo, MI 49001 / US
Inventor(s)01 / PEARLMAN, Bruce, Allen
3411 Willow Lake Drive, 308
Kalamazoo, MI 49008 / US
02 / ANTOSZ, Frederick, J.
1089 N. 10th Street
Kalamazoo, MI 49009 / US
 [2005/24]
Representative(s)Albrecht, Thomas
Kraus & Weisert
Patentanwälte PartGmbB
Thomas-Wimmer-Ring 15
80539 München / DE
[N/P]
Former [2008/44]Albrecht, Thomas
Kraus & Weisert Patent- und Rechtsanwälte Thomas-Wimmer-Ring 15
80539 München / DE
Former [2005/24]Albrecht, Thomas, Dr.
Kraus & Weisert, Thomas-Wimmer-Ring 15
80539 München / DE
Application number, filing date03774488.519.09.2003
[2005/24]
WO2003US29923
Priority number, dateUS20020411874P19.09.2002         Original published format: US 411874 P
US20020425596P12.11.2002         Original published format: US 425596 P
US2003039283321.03.2003         Original published format: US 392833
[2005/24]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2004037844
Date:06.05.2004
Language:EN
[2004/19]
Type: A1 Application with search report 
No.:EP1539795
Date:15.06.2005
Language:EN
The application published by WIPO in one of the EPO official languages on 06.05.2004 takes the place of the publication of the European patent application.
[2005/24]
Type: B1 Patent specification 
No.:EP1539795
Date:31.10.2007
Language:EN
[2007/44]
Search report(s)International search report - published on:EP06.05.2004
ClassificationIPC:C07J21/00
[2005/24]
CPC:
C07J1/00 (EP,US); C07J21/00 (EP,US)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   RO,   SE,   SI,   SK,   TR [2005/24]
Extension statesALNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
TitleGerman:KRISTALLINES GAMMA-LACTON DER17BETA-HYDROXY-7ALPHA-(5'-METHYL-2'-FURYL)-PREGNA-4,9(11)-DIEN-3-ONE-21-CARBONSÄURE[2005/24]
English:CRYSTALLINE 17BETA-HYDROXY-7ALPHA-(5'-METHYL-2'-FURYL)-PREGNA-4,9(11)-DIEN-3-ONE-21-CARBOXYLIC ACID, GAMMA-LACTONE[2005/24]
French:GAMMA-LACTONE DE L'ACIDE CARBOXYLIQUE 17BETA-HYDROXY-7ALPHA-(5'-METHYL-2'-FURYL)-PREGNA-4,9(11)-DIENE-3-ONE-21[2005/24]
Entry into regional phase16.03.2005National basic fee paid 
16.03.2005Designation fee(s) paid 
16.03.2005Examination fee paid 
Examination procedure16.03.2005Amendment by applicant (claims and/or description)
16.03.2005Examination requested  [2005/24]
11.08.2006Despatch of a communication from the examining division (Time limit: M04)
20.12.2006Reply to a communication from the examining division
14.03.2007Communication of intention to grant the patent
12.07.2007Fee for grant paid
12.07.2007Fee for publishing/printing paid
Opposition(s)01.08.2008No opposition filed within time limit [2008/41]
Fees paidRenewal fee
05.09.2005Renewal fee patent year 03
08.09.2006Renewal fee patent year 04
12.09.2007Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT31.10.2007
BE31.10.2007
CH31.10.2007
CY31.10.2007
CZ31.10.2007
DK31.10.2007
EE31.10.2007
FI31.10.2007
LI31.10.2007
NL31.10.2007
RO31.10.2007
SI31.10.2007
SK31.10.2007
TR31.10.2007
BG31.01.2008
SE31.01.2008
GR01.02.2008
PT31.03.2008
HU01.05.2008
[2010/37]
Former [2010/34]AT31.10.2007
BE31.10.2007
CH31.10.2007
CY31.10.2007
CZ31.10.2007
DK31.10.2007
EE31.10.2007
FI31.10.2007
LI31.10.2007
NL31.10.2007
RO31.10.2007
SI31.10.2007
SK31.10.2007
BG31.01.2008
SE31.01.2008
GR01.02.2008
PT31.03.2008
HU01.05.2008
Former [2009/34]AT31.10.2007
BE31.10.2007
CH31.10.2007
CY31.10.2007
CZ31.10.2007
DK31.10.2007
EE31.10.2007
FI31.10.2007
LI31.10.2007
NL31.10.2007
RO31.10.2007
SI31.10.2007
SK31.10.2007
BG31.01.2008
SE31.01.2008
GR01.02.2008
PT31.03.2008
Former [2009/22]AT31.10.2007
BE31.10.2007
CH31.10.2007
CZ31.10.2007
DK31.10.2007
EE31.10.2007
FI31.10.2007
LI31.10.2007
NL31.10.2007
RO31.10.2007
SI31.10.2007
SK31.10.2007
BG31.01.2008
SE31.01.2008
GR01.02.2008
PT31.03.2008
Former [2009/13]AT31.10.2007
BE31.10.2007
CH31.10.2007
CZ31.10.2007
DK31.10.2007
FI31.10.2007
LI31.10.2007
NL31.10.2007
RO31.10.2007
SI31.10.2007
SK31.10.2007
BG31.01.2008
SE31.01.2008
GR01.02.2008
PT31.03.2008
Former [2008/39]AT31.10.2007
BE31.10.2007
CH31.10.2007
CZ31.10.2007
DK31.10.2007
LI31.10.2007
NL31.10.2007
RO31.10.2007
SI31.10.2007
SK31.10.2007
BG31.01.2008
SE31.01.2008
PT31.03.2008
Former [2008/35]AT31.10.2007
CH31.10.2007
CZ31.10.2007
DK31.10.2007
LI31.10.2007
NL31.10.2007
SI31.10.2007
BG31.01.2008
SE31.01.2008
PT31.03.2008
Former [2008/29]AT31.10.2007
CH31.10.2007
LI31.10.2007
NL31.10.2007
SI31.10.2007
BG31.01.2008
SE31.01.2008
PT31.03.2008
Former [2008/26]CH31.10.2007
LI31.10.2007
NL31.10.2007
SI31.10.2007
BG31.01.2008
SE31.01.2008
PT31.03.2008
Former [2008/24]CH31.10.2007
LI31.10.2007
NL31.10.2007
BG31.01.2008
SE31.01.2008
PT31.03.2008
Cited inInternational search[A]US4559332  (GROB JUERGEN [CH], et al) [A] 1-11 * example 1 *;
 [A]WO9721720  (SEARLE & CO [US]) [A] 1-11 * the whole document *;
 [A]WO9825948  (SEARLE & CO [US], et al) [A] 1-11* the whole document *;
 [E]WO03082894  (PHARMACIA CORP [US], et al) [E] 1-11 * Cpd (VII);; claim 187 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.